Given the critical roles AR plays in PCa progression, advanced PCa is often treated with an androgen deprivation therapy (ADT)-based regimen, which depletes the natural ligands of AR, testosterone and dihydrotestosterone. The gene discussed is AR; the disease is posterior cortical atrophy.